Skip to main content
. 2019 Mar 7;2019:9496419. doi: 10.1155/2019/9496419

Figure 2.

Figure 2

The involvement of survivin in the antiapoptotic effect of a nicotinic agonist. (a-d) NRC were exposed to CVB3 for 2 h and then treated with nicotine (0, 0.001, 0.01, 0.1, 1, and 10 μM) for 36 h. The total proteins were then collected for western blot. ∗∗P < 0.01 vs. control group. (e-h) NRC were exposed to CVB3 for 2 h and then treated with 1 μM nicotine for different times (24 h, 36 h, 48 h, and 60 h). The control group was cultured for 24 h in the absence of nicotine after CVB3 infection. The total proteins were then collected for western blot. ∗∗P < 0.01 vs. control group.